Early radiotherapy after radical prostatectomy improves cancer‐specific survival only in patients with highly aggressive prostate cancer: Validation of recently released criteria
暂无分享,去创建一个
F. Montorsi | G. Gandaglia | A. Briganti | P. Karakiewicz | Q. Trinh | Simon P. Kim | Maxine Sun | F. Abdollah | V. Trudeau | P. Nguyen | M. Sun
[1] F. Burkhard,et al. Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. , 2008, European urology.
[2] U. Capitanio,et al. Impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy. , 2014, European urology.
[3] F. Montorsi,et al. Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics. , 2012, The Journal of urology.
[4] L. Hendrix,et al. Trends in the use of postprostatectomy therapies for patients with prostate cancer: A Surveillance, Epidemiology, and End Results Medicare analysis , 2013, Cancer.
[5] A. Garden,et al. Reduced feeding tube duration with intensity‐modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results‐Medicare Analysis , 2017, Cancer.
[6] R. Gray. A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .
[7] S. Goldenberg,et al. Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline. , 2013, The Journal of urology.
[8] A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer. , 2008, Urology.
[9] R. Valicenti,et al. The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis. , 1999, International journal of radiation oncology, biology, physics.
[10] A. Haese*,et al. Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage. , 2010, The Journal of urology.
[11] C. Perneel,et al. A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[12] L. Holmberg,et al. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. , 1997, JAMA.
[13] S. Lipsitz,et al. Patterns of care and outcomes of radiotherapy for lymph node positivity after radical prostatectomy , 2013, BJU international.
[14] E. Messing,et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. , 2009, The Journal of urology.
[15] E. B. Butler,et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. , 2004, JAMA.
[16] U. Capitanio,et al. Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis. , 2013, European urology.
[17] L. Collette,et al. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) , 2012, The Lancet.
[18] F. Montorsi,et al. Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis. , 2012, European urology.
[19] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[20] J L Warren,et al. Development of a comorbidity index using physician claims data. , 2000, Journal of clinical epidemiology.
[21] Richard K Valicenti,et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] Misop Han,et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. , 2011, The Journal of urology.
[23] N. Willich,et al. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] M. Kattan,et al. Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy. , 2009, The Journal of urology.
[26] F. Fazio,et al. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. , 2009, European urology.
[27] L. Lacombe,et al. The impact of solitary and multiple positive surgical margins on hard clinical end points in 1712 adjuvant treatment-naive pT2-4 N0 radical prostatectomy patients. , 2013, European urology.
[28] Deborah Schrag,et al. Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population , 2002, Medical care.